During Cancer Crosslinks 2019 one thing was crystal clear: there is a need to include broader genomic testing into treatments for cancer patients in Norway.
Why is a Nordic mentor network a good idea for Norwegian start ups working in cancer?
Today, Thursday 17 January, we broadcast LIVE from our conference Cancer Crosslinks at Oslo Cancer Cluster Innovation Park.
New research could help to streamline the development of exciting new immunotherapy approaches for treating cancer.
How can research help implement the next wave of precision oncology for patients? Meet the experts behind the research.
A prestigious EU-grant will advance OncoImmunity’s machine-learning approach to develop personalized cancer immunotherapy.